KBLB Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue

Kraig Biocraft Laboratories’ Spider Silk Advancements Featured as the Cover of National Geographic's March 2026 Issue

ANN ARBOR, Mich., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced that its groundbreaking work in commercializing spider silk is featured on the cover of the March 2026 issue of National Geographic magazine.

National Geographic highlights Kraig Labs’ advancements in producing spider silk fibers using genetically enhanced silkworms. The article includes a graphic that describes the significant advantages of a silkworm-based platform (Kraig Labs Technology). Those advantages include being the most cost-efficient and highest-quality technology for commercializing spider silk. This breakthrough approach combines the scalability of silkworm cultivation with the exceptional performance properties of spider silk. The feature explores both the technical advantages of Kraig’s approach and the growing commercial opportunities of spider silk biomaterials.

Being recognized by a publication with the global reach and historic legacy of National Geographic represents a major milestone for Kraig Labs and for the broader field of biomaterials innovation.

Kraig Labs hosted a team from National Geographic at the Company's research center for three days of interviews, facility tours, and photography. That visit resulted in the striking cover image and an in-depth feature exploring the science and progress behind next-generation spider silk materials. During their visit, Kraig Labs recombinant spider silk was put to the test, towing a car across a parking lot and suspending a person from the ceiling on a single 0.35-ounce loop of thread.  

Due to strict confidentiality and publication agreements, the Company was unable to discuss this publicly until the issue was officially released. Kraig Labs is now proud to share this achievement with its shareholders and partners.

Kraig Labs extends its sincere thanks to the entire National Geographic editorial and photography team for their professionalism and dedication in bringing this story to a global audience.

"We are honored to have our work recognized by one of the world's most respected publications. Our recombinant spider silk technology holds amazing potential across numerous applications from apparel to medicines, industry, and defense technologies," said Kim Thomspon, Kraig Labs CEO, founder, and inventor of the technology. "With our production operations set to kick into high gear, our team is eager to begin supplying the markets with this amazing material."

Kraig Labs continues to advance commercialization of its recombinant spider silk technologies as global interest grows in high-performance, sustainable fiber and fabric solutions.

Interested persons can order a copy of the magazine from National Geographic at .

You can purchase a digital copy of the article directly from National Geographic at

** Photography by Mark Thiessen, NGM Staff, Image Copyright: National Geographic Magazine

For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit .

For details about recent Kraig Labs advancements, please watch the Company's investor updates at or on the Company's YouTube Channel .

To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to   

* For a description of our historical leadership in this technology, please follow this link

Kraig Labs Technology is built on a scientifically engineered silkworm, which incorporates key spider silk proteins to produce recombinant spider silk.

About Kraig Biocraft Laboratories, Inc.

Kraig Biocraft Laboratories, Inc. (), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.

The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information

Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, Inc.

(720) 288-8495

A photo accompanying this announcement is available at



EN
23/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kraig Biocraft Laboratories Inc.

 PRESS RELEASE

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Productio...

Kraig Biocraft Laboratories Deploys Over 700,000 BAM-1 Alpha Production Hybrids, Achieving Key Milestone in its Aggressive Scale-Up Plan ANN ARBOR, Mich., March 30, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced the successful deployment of more than 700,000 BAM-1 Alpha production hybrids of its previously reported 1,000,000 egg inventory. These silkworms are now in active production. This achievement underscores the Company's continued execution of its previou...

 PRESS RELEASE

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas B...

Kraig Biocraft Laboratories Increases R&D Capacity, as Project Atlas Breakthroughs Creating New Spider Silk Transgenics ANN ARBOR, Mich., March 23, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a significant expansion of its research and development capacity designed to keep pace with rapid progress of its advanced materials initiative, Project Atlas. The Company has expanded its laboratory capabilities, onboarding new scientific personnel and the deploymen...

 PRESS RELEASE

Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commerci...

Engineered Silkworms Spin Spider Silk as Biotech Firm Targets Commercial Scale DENVER, March 18, 2026 (GLOBE NEWSWIRE) --  -- A biotechnology company developing genetically engineered silkworms says it’s moving toward commercial production of spider silk, a material long sought by researchers for its unusual combination of strength and elasticity. Kraig Biocraft Laboratories (OTCQB: KBLB) deployed one million genetically engineered silkworm eggs across multiple production facilities in Vietnam as part of a Spring scale-up effort that could eventually produce around 10 metric tons of reco...

 PRESS RELEASE

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making DENVER, March 11, 2026 (GLOBE NEWSWIRE) -- -- In technology and biotechnology, “unicorn” status is typically reserved for private companies valued at $1 billion or more; often backed by major venture rounds, institutional syndicates, and aggressive capital deployment strategies. But what happens when a company advances a platform with billion-dollar potential without the backing of Silicon Valley mega-funding? That question is increasingly being asked about Kraig Biocraft Laboratories (OTCQB: KBLB). More than a decade ...

 PRESS RELEASE

Kraig Biocraft Laboratories Targets New Industrial and Defense Biomate...

Kraig Biocraft Laboratories Targets New Industrial and Defense Biomaterials as "Project Atlas" Hits Major Milestone ANN ARBOR, Mich., March 05, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("the Company", "Kraig Labs", or "Kraig's"), a world leader in spider silk technology*, today announced a major milestone in "Project Atlas", the Company's next-generation bioengineering initiative aimed at creating entirely new classes of materials for industrial and defense applications. Kraig Labs first disclosed the existence of Project Atlas on January 19th, 2026, when ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch